RocketDNA's strategic capital raise success

RocketDNA (ASX:RKT) has successfully completed its Share Purchase Plan (SPP), raising $880,240. The technology service company specializing in AI and autonomous drones exceeded its initial target due to strong shareholder support, leading to an increased cap. Along with a recent $2.5 million placement, RocketDNA has raised over $3.35 million before costs to scale operations and enhance its drone technology.

Outlook on RocketDNA's capital utilization

RocketDNA has successfully raised over $3.35 million through its Share Purchase Plan and a recent placement, reflecting strong shareholder support. The funds will be strategically used to scale manufacturing of the xBot® Inventory, hire new business development staff, and accelerate deployment of the Drone as First Responder (DFR) Product. Additionally, the company plans to enhance its software capabilities and further develop its Site Tube and xBot® products. RocketDNA remains committed to strengthening its financial position and managing debt effectively, as it continues to expand its presence in the autonomous drone market.

Executive insights on capital raise and strategy

The strong shareholder confidence in RocketDNA’s strategy and vision is evident through this successful capital raise. We are now in a stronger position to accelerate product roll-outs and capitalize on emerging opportunities in autonomous drone solutions.